NHS England: Action for Diabetes

Stethoscope on a keyboard

NHS England has announced a new strategy document for diabetes care, called Action for Diabetes.  The document is for Clinical Commissioning Groups (CCGs), to serve as a reference on the work that is going on across NHS England. It will also be of interest to the wider community interested in diabetes care to see what [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

New guideline for bariatric surgery in type 2 diabetes

A gastric band

Bariatric surgery is increasingly seen as an effective and cost-effective treatment for obesity.  There is even some evidence that it can reverse type 2 diabetes. The American Association of Clinical Endocrinologists (AACE) have co-produced a guideline for bariatric surgery that includes within its scope, its use in patients with type 2 diabetes. The guideline covers: [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

Welsh NHS recommends saxagliptin as an option in type 2 diabetes

The All Wales Medicines Strategy Group has published a recommendation regarding saxagliptin, the DPP-4 inhibitor (Onglyza®) Saxagliptin is recommended as an option for use within NHS Wales for the treatment of adult patients aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with insulin (with or without metformin) [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

New guidelines for the management of diabetic retinopathy

Retinopathy

The Canadian Ophthalmological Society has published new guidance for the management of diabetic retinopathy. The guideline provides explicit account of the methods used to identify and evaluate the evidence and arrive at consensus.  Recommendations for clinical practice are set apart from the text that describes the evidence. The guideline covers: Definitions of disease Epidemiologyof diabetes [read the full story…]

Linagliptin rejected by the NHS in Wales for use in type 2 diabetes due to lack of evidence of efficacy

A pen ticking off a checklist

We previously reported systematic reviews of DPP-4 inhibitors.  Recently, the All Wales Medicines Strategy Group, the government agency charged with assessing the effectiveness of medicines and making recommendations about their use in the NHS in Wales, issued an evaluation of linagliptin, a DPP-4 inhibitor marketed under the brand name Trajenta. Clinical question: In patients with [read the full story…]

ACP guidance for treating type 2 diabetes with oral agents

A pen ticking off a checklist

The American College of Physicians has issued updated guidance on managing type 2 diabetes with oral antidiabetic drugs (OADs). The guideline includes a systematic review of the evidence on efficacy regarding various comparisons of monotherapy and combined therapy. Scope: Methods Comparative Effectiveness of Type 2 Diabetes Medications on Intermediate Outcomes Comparative Effectiveness of Type 2 [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

Canadian guidelines for managing diabetic retinopathy

Retinopathy

The Canadian Journal of Opthalmology has recently published guidelines for managing diabetic retinopathy by the Canadian Ophthalmological Society. Coverage: Methodology Definitions Epidemiology Screening Telehealth and Teleophthalmology Risk Factors For And Prevention Of Progression Of Diabetic Retinopathy Treatment Modalities Pregnancy Neovascularization of The Iris Economic Considerations Support Appraisal hints: Does this guidance conform to AGREE principles? [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

New NICE guidance on preventing type 2 diabetes in high risk individuals

Photograph of a bowl of fruit

The National Institute for Health and Clinical Excellence (NICE) has just published important guidance for everyone who is involved identifying people at high risk of type 2 diabetes and in preventing or delaying its onset. This includes GPs, nurses and other health professionals, as well as commissioners and managers within the NHS, local authorities and [read the full story…]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email